These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
436 related articles for article (PubMed ID: 16815246)
1. Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration. Ergun E; Maár N; Ansari-Shahrezaei S; Wimpissinger B; Krepler K; Wedrich A; Stur M Am J Ophthalmol; 2006 Jul; 142(1):10-16. PubMed ID: 16815246 [TBL] [Abstract][Full Text] [Related]
2. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration. Augustin AJ; Schmidt-Erfurth U Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209 [TBL] [Abstract][Full Text] [Related]
3. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration. Augustin AJ; Schmidt-Erfurth U Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797 [TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Spaide RF; Sorenson J; Maranan L Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567 [TBL] [Abstract][Full Text] [Related]
5. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Spaide RF; Sorenson J; Maranan L Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166 [TBL] [Abstract][Full Text] [Related]
6. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial. Chaudhary V; Mao A; Hooper PL; Sheidow TG Ophthalmology; 2007 Dec; 114(12):2183-9. PubMed ID: 18054638 [TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study. Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600 [TBL] [Abstract][Full Text] [Related]
9. Visual acuity and contrast sensitivity outcomes in Indian eyes undergoing photodynamic therapy with intravitreal injection of triamcinolone acetonide in age-related macular degeneration. Kumar A; Sinha S; Kumar V Indian J Ophthalmol; 2007; 55(3):207-11. PubMed ID: 17456939 [TBL] [Abstract][Full Text] [Related]
10. The temporal sequence of combined intravitreal triamcinolone acetonide and photodynamic therapy for exudative age-related macular degeneration. Roth DB; Kulkarni KM; Feuer WJ Ophthalmic Surg Lasers Imaging; 2008; 39(1):12-6. PubMed ID: 18254345 [TBL] [Abstract][Full Text] [Related]
11. Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration. Kaiser PK; ; Boyer DS; Garcia R; Hao Y; Hughes MS; Jabbour NM; Kaiser PK; Mieler W; Slakter JS; Samuel M; Tolentino MJ; Roth D; Sheidow T; Strong HA Ophthalmology; 2009 Apr; 116(4):747-55, 755.e1. PubMed ID: 19243834 [TBL] [Abstract][Full Text] [Related]
12. Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin. Nicolò M; Ghiglione D; Lai S; Nasciuti F; Cicinelli S; Calabria G Retina; 2006 Jan; 26(1):58-64. PubMed ID: 16395140 [TBL] [Abstract][Full Text] [Related]
13. Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration. ; Gilson MM; Bressler NM; Jabs DA; Solomon SD; Thorne JE; Wilson DJ Ophthalmology; 2007 Sep; 114(9):1713-21. PubMed ID: 17822977 [TBL] [Abstract][Full Text] [Related]